EDITORIAL
Published on 18 Mar 2021
Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
doi 10.3389/fpsyt.2021.662963
- 3,635 views
- Frontiers in Psychiatry
- Psychopharmacology
- Research Topics
- Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
39k
Total downloads
315k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 23 Dec 2020
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
doi 10.3389/fpsyt.2020.595584
- 327,791 views
- 222 citations
REVIEW
Published on 19 Nov 2020
Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
doi 10.3389/fpsyt.2020.548505
- 32,118 views
- 49 citations
REVIEW
Published on 15 May 2020
Pharmacological Treatment of Anxiety Disorders: The Role of the HPA Axis
doi 10.3389/fpsyt.2020.00443
- 34,306 views
- 117 citations
STUDY PROTOCOL
Published on 13 Dec 2019
A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD
doi 10.3389/fpsyt.2019.00846
- 21,233 views
- 15 citations
Published in
Frontiers in Psychiatry
- Psychopharmacology
- Mood Disorders
Impact
- 315kTopic views
- 273kArticle views
- 39kArticle downloads